Physician profile
Chitradeep De
NPI 1033354873
$2,848.97
in general payments reported to CMS, 2019-2025
23 companies · $358 in 2025
The $358 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $365 · 2021: $471 · 2022: $261 · 2023: $465 · 2024: $313 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $635.55 | 2019-2024 | Zilver Ptx |
| Cardiovascular Systems INC. | $326.03 | 2019-2023 | Diamondback Coronary, Diamondback Peripheral |
| Amgen INC. | $296.56 | 2019-2024 | Repatha |
| Abbott Laboratories | $292.31 | 2021-2025 | Triclip, Diamondback Peripheral, Aveir |
| Boston Scientific Corporation | $238.10 | 2023-2024 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Watchman Access System |
| Philips North America LLC | $225.08 | 2021-2024 | (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Janssen Pharmaceuticals, INC | $222.32 | 2020-2024 | Xarelto |
| Cvrx, INC. | $100.21 | 2023-2025 | Barostim Neo System |
| Abiomed | $85.81 | 2019-2025 | |
| Stryker Corporation | $81.10 | 2025 | Flowtriever |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.46 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $41.86 | 2024 | Arcalyst |
| Medtronic, INC. | $39.11 | 2023-2024 | Reveal Linq, Micra |
| Novo Nordisk INC | $38.50 | 2022-2024 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $28.60 | 2025 | Verquvo |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $27.22 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.22 | 2023-2024 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $16.50 | 2023 | Inpefa |
| Acist Medical Systems, INC. | $16.14 | 2019 | |
| Medtronic Vascular, INC. | $15.23 | 2019 | |
| Scpharmaceuticals INC. | $14.89 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $14.05 | 2019 | |
| Biotronik INC. | $12.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chitradeep De listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.